tiprankstipranks
Trending News
More News >
Biomaxima SA (DE:944)
:944
Germany Market
Advertisement

Biomaxima SA (944) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Biomaxima SA’s (944) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Biomaxima SA is a Sell.
Biomaxima SA’s (944) 20-Day exponential moving average is 2.67, while Biomaxima SA’s (944) share price is €2.79, making it a Buy.
Biomaxima SA’s (944) 50-Day exponential moving average is 2.66, while Biomaxima SA’s (944) share price is €2.79, making it a Buy.

Biomaxima SA (944) Pivot Points

Sep 30, 2025, 10:34 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.63
2.67
2.73
2.77
2.83
2.87
2.93
Fibonacci
2.67
2.70
2.73
2.77
2.80
2.83
2.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biomaxima SA (944) Moving Averages

Sep 30, 2025, 10:34 AM
Period
Simple
Exponential
MA5
2.70Buy
2.73Buy
MA10
2.67Buy
2.69Buy
MA20
2.64Buy
2.67Buy
MA50
2.65Buy
2.66Buy
MA100
2.72Buy
2.67Buy
MA200
2.63Buy
2.65Buy
Biomaxima SA’s (944) 10-Day exponential moving average is 2.69, while Biomaxima SA’s (944) share price is €2.79, making it a Buy.
Biomaxima SA’s (944) 100-Day exponential moving average is 2.67, while Biomaxima SA’s (944) share price is €2.79, making it a Buy.
Biomaxima SA’s (944) stock price is €2.79 and Biomaxima SA’s (944) 50-day simple moving average is 2.65, creating a Buy signal.
Biomaxima SA’s (944) stock price is €2.79 and Biomaxima SA’s (944) 100-day simple moving average is 2.72, creating a Buy signal.
Biomaxima SA’s (944) stock price is €2.79 and Biomaxima SA’s (944) 200-day simple moving average is 2.63, creating a Buy signal.

Biomaxima SA (944) Technical Indicators

Sep 30, 2025, 10:34 AM
Name
Value
Implied Action
RSI (14)
60.63
Neutral
STOCH (9,6)
78.42
Neutral
STOCHRSI (14)
53.51
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
15.12
Buy
Williams %R
-35.48
Buy
CCI (14)
173.91
Sell
ATR (14)
0.07
-
Ultimate Oscillator
56.85
Neutral
ROC
8.14
Buy
Biomaxima SA’s (944) Relative Strength Index (RSI) is 60.63, creating a Neutral signal.
Biomaxima SA’s (944) Trend Strength Indicator (ADX) is 15.12, creating a Buy signal.
Biomaxima SA’s (944) Commodity Channel Index (CCI) is 173.91, creating a Sell signal.
Biomaxima SA’s (944) Price Rate of Change (ROC) is 8.14, creating a Buy signal.

FAQ

Is 944 a Buy, Hold, or Sell?
Based on 944’s technical indicators, 944 is a Strong Buy.
    What is 944’s RSI (14)?
    944’s RSI (14) is 60.63, which suggests 944 is a Neutral.
      What is 944’s MACD?
      944’s MACD is 0.02, which suggests 944 is a Sell.
        What is 944’s 5-day moving average?
        944’s 5-day moving average is 2.70, which suggests 944 is a Buy.
          What is 944’s 20-day moving average?
          944 20-day moving average is 2.64, which suggests 944 is a Buy.
            What is 944’s 50-day moving average?
            944’s 50-day moving average is 2.65, which suggests 944 is a Buy.
              What is 944’s 200-day moving average?
              944’s 200-day moving average is 2.63, which suggests 944 is a Buy.
                What is 944’s Williams % R (14)?
                944’s Williams % R (14) is -35.48, which suggests 944 is a Buy.
                  What is 944’s CCI (14)?
                  944’s CCI (14) is 173.91, which suggests 944 is a Sell.
                    What is the share price of Biomaxima SA?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis